[Oral contraceptives, risk factor of myocardial infarction related to blood lipids (author's transl)].
Limouzin-lamothe
M A
MA
Serog
P
P
D001695:Biology; D002319:Cardiovascular System; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D003710:Demography; D004997:Ethinyl Estradiol; D005193:Family Planning Services; D008055:Lipids; D009026:Mortality; D009640:Norethindrone; D009644:Norgestrel; D010827:Physiology; D011153:Population; D011157:Population Dynamics
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D008055:Lipids; D009644:Norgestrel; D004997:Ethinyl Estradiol; D009640:Norethindrone
Age Specific Death Rate; Biology; Cardiovascular Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Death Rate; Demographic Factors; Ethinyl Estradiol; Family Planning; Lipid Metabolic Effects; Lipids; Mortality; Norethindrone; Norgestrel; Oral Contraceptives--side effects; Physiology; Population; Population Dynamics